Study of Multiple-Ascending-Dose Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations
Study of Multiple-Ascending-Dose Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations
Active, not recruiting · NCT05890729 · Registry updated 2026-10-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Multiple-Ascending-Dose Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations | Hemic and Lymphatic Diseases, Hypersensitivity, Delayed, immune system disorder, interstitial lung disease, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, pulmonary sarcoidosis, respiratory system disorder, sarcoidosis | Active, not recruiting | Phase 1 / Phase 2 | 2026-10-02 | NCT05890729 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Xentria, Inc. | 4 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| King's College Hospital NHS Foundation Trust | London | United Kingdom | 2 |
| NHS Tayside | Perth | United Kingdom | 2 |
| Norfolk and Norwich University Hospitals NHS Foundation Trust | Norwich | United Kingdom | 1 |
| Oxford University Hospitals NHS Foundation Trust | Oxford | United Kingdom | 1 |
| University College London Hospitals NHS Foundation Trust | London | United Kingdom | 1 |
| University Hospitals Coventry and Warwickshire NHS Trust | Coventry | United Kingdom | 2 |